Lipocine (LPCN) Reports Q3 Loss Per Share of $0.35

Lipocine (NASDAQ: LPCN) reported Q3 EPS of ($0.35), versus ($0.34) reported last year.

For earnings history and earnings-related data on Lipocine (LPCN) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• AMC Entertainment prices $200M stock offering to redeem senior notes